世界の術中照射療法市場(~2025年):技術別(電子線照射療法、密封小線源療法)、製品・サービス別(加速器、治療計画システム、アプリケーター、アフターローダー、附属品)、用途別(乳房、脳、肺がん)

◆英語タイトル:Intraoperative Radiation Therapy Market by Technology (Electron IORT, Brachytherapy), Products & Services (Accelerators, Treatment Planning system, Applicators, Afterloaders, Accessories), Application (Breast, Brain, Lung Cancer) - Global Forecasts to 2025
◆商品コード:MD7339
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2021年2月15日
◆ページ数:156
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

マーケッツアンドマーケッツ社は、世界の術中照射療法市場規模が2020年48百万ドルから2025年66百万ドルまで、年平均6.4%成長すると予測しています。本調査レポートでは、術中照射療法の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品・サービス別(システム・加速装置、アプリケーター・アフターローダー、治療計画システム、附属品、サービス)分析、技術別(電子線照射療法、密封小線源療法)分析、用途別(乳がん、脳腫瘍、消化器がん、頭頸部がん、結腸直腸癌)分析、地域別分析、競争状況、企業情報などを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・術中照射療法の世界市場規模:製品・サービス別(システム・加速装置、アプリケーター・アフターローダー、治療計画システム、附属品、サービス)
・術中照射療法の世界市場規模:技術別(電子線照射療法、密封小線源療法)
・術中照射療法の世界市場規模:用途別(乳がん、脳腫瘍、消化器がん、頭頸部がん、結腸直腸癌)
・術中照射療法の世界市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

“The global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period.”
The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market. Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players. However, the complex nature of technology coupled with a shortage of trained personnel and preference of conventional radiotherapy over IORT by physicians owing to reimbursement coverage are the major factors that are expected to restrain the growth of this market.

“The system/accelerators segment is expected to account for the largest market share during the forecast period.”
Based on product type, the intraoperative radiation therapy market products market is segmented into system/accelerators, treatment planning systems, applicators & afterloaders, and accessories. The systems/accelerators segment is expected to account for the largest share of the IORT products market in 2019. The large share of this segment can be attributed to the low cost of accelerators as compared to advanced radiosurgery products, growing applications of IORT products in cancer treatment, and the development of technologically advanced mobile systems/accelerators.

“The breast cancer segment is expected to hold the largest share of the intraoperative radiation therapy market, by application, during the forecast period.”
Based on application, the intraoperative radiation therapy market is segmented into breast cancer, brain tumor, gastrointestinal cancer, head and neck cancer, colorectal cancer, endometrial and cervical cancer, lung cancer, and other cancers. The breast cancer segment is expected to account for the largest share of this market in 2019. The large share of this segment can be attributed to a high prevalence of breast cancer, coupled with advantages offered by IORT such as the reduced amount of irradiation, shorter treatment time, and lesser clinical risks.

“Europe to account for the second-largest share of the global market in 2019.”
The intraoperative radiation therapy market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and Middle East and Africa. Europe is expected to account for the second-largest share of the global intraoperative radiation therapy market in 2019. The growing incidence of cancer, supportive government initiatives, and the implementation of intraoperative radiation therapy market training programs & conferences/symposiums are the major factors propelling the demand for intraoperative radiation therapy market products in Europe. Furthermore, several key market players are focusing on enhancing their intraoperative radiation therapy market products to improve the quality of patient care across Europe.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–45%, Tier 2–34%, and Tier 3– 21%
• By Designation: C-level–47%, Director-level–33%, and Others–20%
• By Region: North America–35%, Europe–32%, Asia Pacific–25%, Latin America–6%, and the Middle East & Africa–2%

Some of the prominent players in the antimicrobial susceptibility testing market include ZEISS Group (Germany), iCAD, Inc. (US), Eckert & Ziegler (Germany), Elekta AB (Sweden), GMV Innovating Solutions (Spain), Sensus Healthcare, Inc. (US), IntraOp Medical, Inc. (US), Isoray, Inc. (US), Becton, Dickinson and Company (US), Sordina IORT Technologies (Italy), Varian Medical Systems, Inc. (US), SeeDos Ltd. (UK), IsoAid LLC (US), Ariane Medical Systems Ltd. (UK), Panacea Medical Technologies Pvt. Ltd. (India), Salutaris Medical Devices (US), Brainlab AG (Germany), RaySearch Laboratories (Sweden), REMEDI Co., Ltd. (South Korea), Merit Medical Systems, Inc. (US), among others.

Research Coverage
This report studies the IORT market based on product and service, technology, application, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
 Market Penetration: Comprehensive information on the product portfolios offered by the top players in the Intraoperative radiation therapy market
 Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the Intraoperative radiation therapy market
 Market Development: Comprehensive information on lucrative emerging regions
 Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the Intraoperative radiation therapy market
 Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

【レポートの目次】

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED FOR THE STUDY 21
1.4 CURRENCY USED FOR THE STUDY 22
1.5 STAKEHOLDERS 22
1.6 SUMMARY OF CHANGES 22
2 RESEARCH METHODOLOGY 23
2.1 RESEARCH DATA 23
FIGURE 1 RESEARCH DESIGN 23
2.1.1 SECONDARY DATA 23
2.1.1.1 Secondary sources 25
2.1.2 PRIMARY DATA 25
2.1.2.1 Breakdown of primaries 26
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: INTRAOPERATIVE RADIATION THERAPY MARKET 26
2.2 MARKET ESTIMATION METHODOLOGY 26
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 27
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 27
2.2.2 END USER-BASED MARKET ESTIMATION 28
FIGURE 4 MARKET SIZE ESTIMATION: INTRAOPERATIVE RADIATION THERAPY MARKET 28
2.2.3 PRIMARY RESEARCH VALIDATION 29
2.3 DATA TRIANGULATION 30
FIGURE 5 DATA TRIANGULATION METHODOLOGY 30
2.4 RESEARCH ASSUMPTIONS 31
2.5 RESEARCH LIMITATIONS 31
3 EXECUTIVE SUMMARY 32
FIGURE 6 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION) 32
FIGURE 7 INTRAOPERATIVE RADIATION THERAPY MARKET SHARE, BY TECHNOLOGY, 2020 VS. 2025 33
FIGURE 8 INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 34
FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE INTRAOPERATIVE RADIATION THERAPY MARKET 35

4 PREMIUM INSIGHTS 36
4.1 INTRAOPERATIVE RADIATION THERAPY MARKET OVERVIEW 36
FIGURE 10 GROWING PREVALENCE OF CANCER IS DRIVING THE GROWTH OF THE INTRAOPERATIVE RADIATION THERAPY MARKET 36
4.2 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE,
2020 VS. 2025 (USD MILLION) 37
FIGURE 11 IORT PRODUCTS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD 37
4.3 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION) 37
FIGURE 12 SYSTEMS & ACCELERATORS SEGMENT WILL CONTINUE TO DOMINATE THE NORTH AMERICAN MARKET IN 2025 37
4.4 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY,
2020 VS. 2025 (USD MILLION) 38
FIGURE 13 ELECTRON IORT SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE APAC INTRAOPERATIVE RADIATION THERAPY MARKET 38
4.5 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION & COUNTRY (2019) 39
FIGURE 14 BREAST CANCER SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN INTRAOPERATIVE RADIATION THERAPY MARKET IN 2019 39
4.6 INTRAOPERATIVE RADIATION THERAPY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 40
FIGURE 15 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 40
5 MARKET OVERVIEW 41
5.1 INTRODUCTION 41
5.2 MARKET DYNAMICS 41
FIGURE 16 INTRAOPERATIVE RADIATION THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41
5.2.1 DRIVERS 42
5.2.1.1 Growing global prevalence of cancer 42
5.2.1.2 Improving reimbursement scenario 42
TABLE 1 NATIONAL AVERAGE MEDICARE REIMBURSEMENT CPT CODES, 2019 42
5.2.1.3 Procedural advantages over EBRT 43
5.2.1.4 Technological advancements 43
5.2.2 RESTRAINTS 44
5.2.2.1 Dearth of trained personnel 44
5.2.2.2 Strong market positioning of alternative therapies 44
TABLE 2 ALTERNATIVES TO IORT PROCEDURES 44
5.2.3 OPPORTUNITIES 45
5.2.3.1 Emerging economies offer high growth potential 45
5.2.3.2 Growing applications of IORT 45
5.2.4 CHALLENGES 46
5.2.4.1 Risk of radiation exposure 46
5.3 IMPACT OF COVID-19 ON THE INTRAOPERATIVE RADIATION THERAPY MARKET 46
5.4 GLOBAL REGULATORY SCENARIO 48
5.4.1 NORTH AMERICA 48
5.4.1.1 US 48
TABLE 3 US: MEDICAL DEVICE CLASSIFICATION 49
TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 49
5.4.1.2 Canada 50
TABLE 5 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 50
FIGURE 17 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 51
5.4.2 EUROPE 52
FIGURE 18 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR) 53
5.4.3 ASIA PACIFIC 54
5.4.3.1 Japan 54
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 54
5.4.3.2 China 55
TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES 55
5.4.3.3 India 56
5.5 VALUE CHAIN ANALYSIS: GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET 57
FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING THE MANUFACTURING PHASE 57
5.6 ECOSYSTEM COVERAGE: GLOBAL RADIOTHERAPY MARKET 58
6 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE 59
6.1 INTRODUCTION 60
TABLE 8 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 60
6.2 IORT PRODUCTS 60
TABLE 9 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 61
TABLE 10 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION) 61
6.2.1 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY TECHNOLOGY 62
TABLE 11 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 62
6.2.2 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY APPLICATION 62
TABLE 12 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 62
6.2.3 SYSTEMS & ACCELERATORS 63
6.2.3.1 Affordability of systems & accelerators is supporting their adoption 63
TABLE 13 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SYSTEMS & ACCELERATORS, BY REGION, 2018–2025 (USD MILLION) 63
6.2.3.2 Intraoperative radiation therapy market for systems & accelerators, by technology 64
TABLE 14 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SYSTEMS & ACCELERATORS, BY TECHNOLOGY, 2018–2025 (USD MILLION) 64
6.2.3.3 Intraoperative radiation therapy market for systems & accelerators, by application 64
TABLE 15 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SYSTEMS & ACCELERATORS, BY APPLICATION, 2018–2025 (USD MILLION) 64
6.2.4 APPLICATORS & AFTERLOADERS 65
6.2.4.1 Growing approvals of applicators & afterloaders for the treatment of different cancer types is supporting the growth of this segment 65
TABLE 16 INTRAOPERATIVE RADIATION THERAPY MARKET FOR APPLICATORS & AFTERLOADERS, BY REGION, 2018–2025 (USD MILLION) 65
6.2.4.2 Intraoperative radiation therapy market for applicators & afterloaders, by technology 66
TABLE 17 INTRAOPERATIVE RADIATION THERAPY MARKET FOR APPLICATORS & AFTERLOADERS, BY TECHNOLOGY, 2018–2025 (USD MILLION) 66
6.2.4.3 Intraoperative radiation therapy market for applicators & afterloaders, by application 66
TABLE 18 INTRAOPERATIVE RADIATION THERAPY MARKET FOR APPLICATORS & AFTERLOADERS, BY APPLICATION, 2018–2025 (USD MILLION) 66
6.2.5 TREATMENT PLANNING SYSTEMS 67
6.2.5.1 Technological advancements & growing regulatory approvals are supporting market growth 67
TABLE 19 INTRAOPERATIVE RADIATION THERAPY MARKET FOR TREATMENT PLANNING SYSTEMS, BY REGION, 2018–2025 (USD MILLION) 67
6.2.5.2 Intraoperative radiation therapy market for treatment planning systems, by technology 68
TABLE 20 INTRAOPERATIVE RADIATION THERAPY MARKET FOR TREATMENT PLANNING SYSTEMS, BY TECHNOLOGY, 2018–2025 (USD MILLION) 68
6.2.5.3 Intraoperative radiation therapy market for treatment planning systems, by application 68
TABLE 21 INTRAOPERATIVE RADIATION THERAPY MARKET FOR TREATMENT PLANNING SYSTEMS, BY APPLICATION, 2018–2025 (USD MILLION) 68
6.2.6 ACCESSORIES 69
6.2.6.1 Growing number of IORT procedures to drive the adoption of IORT accessories 69
TABLE 22 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ACCESSORIES,
BY REGION, 2018–2025 (USD MILLION) 69
6.2.6.2 Intraoperative radiation therapy market for accessories,
by technology 70
TABLE 23 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ACCESSORIES,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 70
6.2.6.3 Intraoperative radiation therapy market for accessories,
by application 70
TABLE 24 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ACCESSORIES,
BY APPLICATION, 2018–2025 (USD MILLION) 70
6.3 IORT SERVICES 71
6.3.1 NEED FOR FREQUENT SOFTWARE UPGRADES TO DRIVE MARKET GROWTH 71
TABLE 25 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES, BY REGION, 2018–2025 (USD MILLION) 71
6.3.2 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES,
BY TECHNOLOGY 71
TABLE 26 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 71
6.3.3 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES,
BY APPLICATION 72
TABLE 27 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES,
BY APPLICATION, 2018–2025 (USD MILLION) 72
7 INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY 73
7.1 INTRODUCTION 74
TABLE 28 INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 74
7.2 ELECTRON IORT 74
7.2.1 MINIMAL TREATMENT TIME OF THIS PROCEDURE HAS INCREASED ITS ADOPTION IN THE MARKET 74
TABLE 29 PROMISING CLINICAL TRIALS FOR ELECTRON IORT 74
TABLE 30 ELECTRON IORT MARKET, BY REGION, 2018–2025 (USD MILLION) 75
7.3 INTRAOPERATIVE BRACHYTHERAPY 75
7.3.1 LOWER COST THAN IOERT & BETTER DOSIMETRIC DISTRIBUTION ARE THE KEY FACTORS SUPPORTING MARKET GROWTH 75
TABLE 31 INTRAOPERATIVE BRACHYTHERAPY MARKET, BY REGION,
2018–2025 (USD MILLION) 76
8 INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION 77
8.1 INTRODUCTION 78
TABLE 32 INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 78
8.2 BREAST CANCER 78
8.2.1 GROWING NUMBER OF BREAST CANCER CASES ACROSS THE GLOBE IS FUELING THE ADOPTION OF IORT 78
TABLE 33 INTRAOPERATIVE RADIATION THERAPY MARKET FOR BREAST CANCER,
BY REGION, 2018–2025 (USD MILLION) 79
8.3 BRAIN TUMOR 79
8.3.1 GROWING NUMBER OF BRAIN TUMOR CASES TO DRIVE MARKET GROWTH 79
TABLE 34 INTRAOPERATIVE RADIATION THERAPY MARKET FOR BRAIN TUMOR,
BY REGION, 2018–2025 (USD MILLION) 80
8.4 GASTROINTESTINAL CANCER 80
8.4.1 IORT OFFERS A SUITABLE ALTERNATIVE FOR GASTROINTESTINAL CANCER TREATMENT AS OPPOSED TO SURGERY OR CONVENTIONAL RADIATION 80
TABLE 35 INTRAOPERATIVE RADIATION THERAPY MARKET FOR GASTROINTESTINAL CANCER, BY REGION, 2018–2025 (USD MILLION) 81
8.5 HEAD & NECK CANCER 81
8.5.1 IORT IS HIGHLY EFFICIENT IN THE TREATMENT OF HEAD & NECK CANCER AS IT OFFERS BETTER TUMOR CONTROL 81
TABLE 36 INTRAOPERATIVE RADIATION THERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 2018–2025 (USD MILLION) 82

8.6 COLORECTAL CANCER 82
8.6.1 IORT IS PROVEN EFFECTIVE FOR ADVANCED LOCAL AND RECURRENT COLORECTAL CANCER TREATMENT IN COMBINATION WITH PREOPERATIVE EBRT 82
TABLE 37 INTRAOPERATIVE RADIATION THERAPY MARKET FOR COLORECTAL CANCER, BY REGION, 2018–2025 (USD MILLION) 83
8.7 ENDOMETRIAL & CERVICAL CANCER 83
8.7.1 IORT IN COMBINATION WITH RADICAL RESECTION PROCEDURES IS A CURATIVE OPTION FOR PATIENTS WITH RECURRENT ENDOMETRIAL CANCER 83
TABLE 38 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ENDOMETRIAL & CERVICAL CANCER, BY REGION, 2018–2025 (USD MILLION) 83
8.8 LUNG CANCER 84
8.8.1 ALTERNATIVE TREATMENT OPTIONS FOR LUNG CANCER IS EXPECTED TO HAMPER THE GROWTH OF THIS SEGMENT 84
TABLE 39 INTRAOPERATIVE RADIATION THERAPY MARKET FOR LUNG CANCER,
BY REGION, 2018–2025 (USD MILLION) 84
8.9 OTHER CANCERS 84
TABLE 40 INTRAOPERATIVE RADIATION THERAPY MARKET FOR OTHER CANCERS,
BY REGION, 2018–2025 (USD MILLION) 85
9 INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION 86
9.1 INTRODUCTION 87
TABLE 41 INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION,
2018–2025 (USD MILLION) 87
9.2 NORTH AMERICA 87
FIGURE 20 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET SNAPSHOT 88
TABLE 42 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 89
TABLE 43 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 89
TABLE 44 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 89
TABLE 45 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 90
9.2.1 US 90
9.2.1.1 Higher adoption rate of innovative technologies to support market growth in the US 90
TABLE 46 US: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 91
9.2.2 CANADA 91
9.2.2.1 Surge in the incidence of cancer and favorable government guidelines to support the market growth 91
TABLE 47 CANADA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 92
9.3 EUROPE 92
TABLE 48 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 93
TABLE 49 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 93
TABLE 50 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 94
TABLE 51 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 94
9.3.1 GERMANY 94
9.3.1.1 Growing awareness about advanced cancer treatment is expected to fuel the adoption of IORT products in Germany 94
TABLE 52 GERMANY: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 95
9.3.2 UK 95
9.3.2.1 Initiatives by public & private organizations to increase awareness about IORT 95
TABLE 53 UK: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 96
9.3.3 FRANCE 96
9.3.3.1 Preference for conventional radiotherapy is restraining the growth of the IORT market in France 96
TABLE 54 FRANCE: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 97
9.3.4 SPAIN 97
9.3.4.1 Growing geriatric population to support market growth 97
TABLE 55 SPAIN: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 98
9.3.5 ITALY 98
9.3.5.1 Rising awareness activities to support market growth 98
TABLE 56 ITALY: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 99
9.3.6 REST OF EUROPE 99
TABLE 57 REST OF EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 100
9.4 ASIA PACIFIC 100
FIGURE 21 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET SNAPSHOT 101
TABLE 58 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 102
TABLE 59 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 102
TABLE 60 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 103
TABLE 61 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 103
9.4.1 CHINA 104
9.4.1.1 Increasing patient pool and government initiatives for healthcare development are fueling the market growth 104
TABLE 62 CHINA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 104
9.4.2 JAPAN 105
9.4.2.1 Presence of universal healthcare reimbursement scenario and rising breast cancer cases—key factors driving market growth 105
TABLE 63 JAPAN: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 105
9.4.3 INDIA 105
9.4.3.1 Government initiatives to improve cancer treatment to drive market growth in India 105
TABLE 64 INDIA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 106
9.4.4 SOUTH KOREA 106
9.4.4.1 Rising R&D and promising clinical trials in the country to positively impact market growth 106
TABLE 65 SOUTH KOREA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 107
9.4.5 AUSTRALIA 107
9.4.5.1 Rising research investments and awareness campaigns are the key factors supporting market growth 107
TABLE 66 AUSTRALIA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 108
9.4.6 REST OF ASIA PACIFIC 108
TABLE 67 REST OF ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 108
9.5 LATIN AMERICA 109
TABLE 68 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 109
TABLE 69 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 109
TABLE 70 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 110
TABLE 71 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 110
9.5.1 BRAZIL 111
9.5.1.1 Brazil is a key market in Latin America owing to the modernization of healthcare facilities 111
TABLE 72 BRAZIL: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 111
9.5.2 MEXICO 111
9.5.2.1 Availability of advanced care and increasing awareness programs are fueling market growth in Mexico 111
TABLE 73 MEXICO: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 112
9.5.3 REST OF LATIN AMERICA 112
TABLE 74 REST OF LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 113
9.6 MIDDLE EAST & AFRICA 113
9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA 113
TABLE 75 MIDDLE EAST & AFRICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 114
TABLE 76 MIDDLE EAST & AFRICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 114
TABLE 77 MIDDLE EAST & AFRICA: INTRAOPERATIVE RADIATION THERAPY MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 115
10 COMPETITIVE LANDSCAPE 116
10.1 OVERVIEW 116
FIGURE 22 KEY DEVELOPMENTS IN THE INTRAOPERATIVE RADIATION THERAPY MARKET FROM 2017 TO 2020 117
10.2 MARKET SHARE ANALYSIS 118
FIGURE 23 INTRAOPERATIVE RADIATION THERAPY MARKET SHARE, BY KEY PLAYER, 2019 118
10.3 KEY MARKET DEVELOPMENTS 119
10.3.1 PRODUCT LAUNCHES & APPROVALS 119
10.3.2 ACQUISITIONS 119
10.3.3 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS 120
10.3.4 EXPANSIONS 120
11 COMPANY EVOLUTION MATRIX AND COMPANY PROFILES 121
11.1 COMPETITIVE EVALUATION MATRIX AND METHODOLOGY 121
11.1.1 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2019) 121
11.1.2 STARS 121
11.1.3 EMERGING LEADERS 121
11.1.4 EMERGING COMPANIES 122
11.1.5 PERVASIVE 122
FIGURE 24 COMPETITIVE LEADERSHIP MAPPING: OVERALL MARKET (2019) 122
FIGURE 25 COMPETITIVE LEADERSHIP MAPPING: EMERGING PLAYERS (2019) 123
11.2 COMPANY PROFILES 124
(Business overview, Products offered, Recent developments, MNM view)*
11.2.1 ZEISS GROUP 124
FIGURE 26 ZEISS GROUP: COMPANY SNAPSHOT (2019) 124
11.2.2 ICAD, INC. 126
FIGURE 27 ICAD, INC.: COMPANY SNAPSHOT (2019) 126
11.2.3 ECKERT & ZIEGLER 128
FIGURE 28 ECKERT & ZIEGLER: COMPANY SNAPSHOT (2019) 128
11.2.4 ARIANE MEDICAL SYSTEMS LTD. 131
11.2.5 BECTON, DICKINSON AND COMPANY 132
FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019) 132
11.2.6 ELEKTA AB 134
FIGURE 30 ELEKTA AB: COMPANY SNAPSHOT (2019) 134
11.2.7 GMV INNOVATING SOLUTIONS 136
11.2.8 INTRAOP MEDICAL, INC. 137
11.2.9 ISOAID, LLC 138
11.2.10 ISORAY, INC. 139
FIGURE 31 ISORAY, INC.: COMPANY SNAPSHOT (2019) 139
11.2.11 PANACEA MEDICAL TECHNOLOGIES PVT. LTD. 141
11.2.12 SEEDOS LTD. 142
11.2.13 SENSUS HEALTHCARE, INC. 143
FIGURE 32 SENSUS HEALTHCARE, INC.: COMPANY SNAPSHOT (2019) 143
11.2.14 S.I.T. SORDINA IORT TECHNOLOGIES S.P.A. 145
11.2.15 VARIAN MEDICAL SYSTEMS, INC. 146
FIGURE 33 VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2019) 146
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
11.2.16 OTHER COMPANIES 149
11.2.16.1 Salutaris Medical Devices 149
11.2.16.2 Brainlab AG 149
11.2.16.3 RaySearch Laboratories 150
11.2.16.4 REMEDI Co., Ltd. 150
11.2.16.5 Merit Medical Systems 151
12 APPENDIX 152
12.1 DISCUSSION GUIDE 152
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 156
12.3 AVAILABLE CUSTOMIZATIONS 158
12.4 RELATED REPORTS 158
12.5 AUTHOR DETAILS 159



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の術中照射療法市場(~2025年):技術別(電子線照射療法、密封小線源療法)、製品・サービス別(加速器、治療計画システム、アプリケーター、アフターローダー、附属品)、用途別(乳房、脳、肺がん)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆